Clover Health Reports Q2 2026 Financial Results

What Happened Clover Health Investments, Corp. announced its financial results for the quarter ended June 30, 2026 via a press release dated August 5, 2026. The company furnished the full text of that press release as Exhibit 99.1 to the Form 8-K filed on August 5, 2026. The report was signed by Clay Thornton, Interim Chief Financial Officer (Principal Financial Officer).

Key Details

• Filing covers quarterly results for the three months ended June 30, 2026 (Q2 2026).
• Press release dated August 5, 2026 is furnished as Exhibit 99.1 to the Form 8-K.
• The Form 8-K includes an Inline XBRL cover page data file (Exhibit 104).
• The report was signed by Clay Thornton, Interim CFO, on August 5, 2026.

Why It Matters Earnings and quarterly results are primary drivers of near-term stock performance and investor decisions. This 8-K signals that Clover has made its Q2 2026 financial results public; retail investors should read the attached press release (Exhibit 99.1) and related periodic filings for the detailed revenue, profit/loss, cash flow, and any management commentary or guidance. The filing also notes the Interim CFO signed the report, which is relevant for who is certifying the financial disclosure.